Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Efficacy Study of Nicorandil on Neointima
Phase 4
- Conditions
- Diabetes MellitusAngina, Unstable
- Interventions
- First Posted Date
- 2014-12-31
- Last Posted Date
- 2015-01-21
- Lead Sponsor
- Zhang Ying Qian
- Target Recruit Count
- 48
- Registration Number
- NCT02328521
- Locations
- 🇨🇳
Chinese PLA General Hospital, Beijing, Beijing, China
News
No news found